Pain and death: Neurodegenerative disease mechanisms in the nociceptor

Annals of Neurology

Volumn 69, Issue 1, 2011, Pages 13-21

  Reichling, David B ^a   Levine, Jon D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA1 INTEGRIN; ALPHA3 INTEGRIN; BETA1 INTEGRIN; CYTOCHROME C1; CYTOCHROME C2; CYTOCHROME C3; CYTOSKELETON PROTEIN; MITOCHONDRIAL DNA; NEUROFILAMENT PROTEIN; PACLITAXEL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; VINCRISTINE; ZALCITABINE;

AEROBIC METABOLISM; ARTICLE; CELL DEATH; CLINICAL FEATURE; DEATH; DEGENERATIVE DISEASE; FUNCTIONAL DISEASE; GENE MUTATION; GENETIC DISORDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPERACTIVITY; MICROTUBULE; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRION; MOLECULAR MECHANICS; NERVE DEGENERATION; NEUROPATHIC PAIN; NOCICEPTIVE RECEPTOR; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SENSORY NERVE CELL; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; CELL DEATH; ENERGY METABOLISM; HUMANS; MITOCHONDRIAL DISEASES; MODELS, NEUROLOGICAL; NERVE FIBERS, MYELINATED; NEURALGIA; NEURODEGENERATIVE DISEASES; NOCICEPTORS; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM; POLYNEUROPATHIES; REACTIVE OXYGEN SPECIES;

EID: 79551468717     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22351     Document Type: Article

References (73)

1. Reichling DB, Levine JD., Critical role of nociceptor plasticity in chronic pain. Trends Neurosci 2009; 32: 611-618.
2. Latremoliere A, Woolf CJ., Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10: 895-926.
3. Apkarian AV, Scholz J., Shared mechanisms between chronic pain and neurodegenerative disease. Drug Discov Today Dis Mech 2006; 3: 319-326.
4. Taylor BK, Peterson MA, Basbaum AI., Persistent cardiovascular and behavioral nociceptive responses to subcutaneous formalin require peripheral nerve input. J Neurosci 1995; 15: 7575-7584.
5. Koltzenburg M, Torebjork HE, Wahren LK., Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain. Brain 1994; 117: 579-591.
6. Cervero F., Visceral pain: mechanisms of peripheral and central sensitization. Ann Med 1995; 27: 235-239.
7. Price DD, Zhou QQ, Moshiree B, et al. Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. J Pain 2006; 7: 529-535.
8. Staud R., Are tender point injections beneficial: the role of tonic nociception in fibromyalgia. Curr Pharm Des 2006; 12: 23-27.
9. Gwilym SE, Fillipini N, Douaud G, et al. Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty; a longitudinal voxel-based-morphometric study. Arthritis Rheum 2010; 62: 2930-2940.
10. Britland ST, Young RJ, Sharma AK, Clarke BF., Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 1990; 39: 898-908.
11. Beiske AG, Loge JH, Ronningen A, Svensson E., Pain in Parkinson's disease: prevalence and characteristics. Pain 2009; 141: 173-177.
12. Ford B., Parkinson disease: pain in Parkinson disease: the hidden epidemic. Nat Rev Neurol 2009; 5: 242-243.
13. Giuffrida R, Vingerhoets FJ, Bogousslavsky J, Ghika J., Pain in Parkinson's disease. Rev Neurol (Paris) 2005; 161: 407-418.
14. Braak H, Sastre M, Bohl JR, et al. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007; 113: 421-429.
15. Djaldetti R, Shifrin A, Rogowski Z, et al. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004; 62: 2171-2175.
16. Mylius V, Engau I, Teepker M, et al. Pain sensitivity and descending inhibition of pain in Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 24-28.
17. Nolano M, Provitera V, Estraneo A, et al. Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation. Brain 2008; 131: 1903-1911.
18. Abele M, Schulz JB, Burk K, et al. Nerve conduction studies in multiple system atrophy. Eur Neurol 2000; 43: 221-223.
19. Gemignani F, Melli G, Alfieri S, et al. Sensory manifestations in Charcot-Marie-Tooth disease. J Peripher Nerv Syst 2004; 9: 7-14.
20. Isaacs JD, Dean AF, Shaw CE, et al. Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder? J Neurol Neurosurg Psychiatry 2007; 78: 750-753.
21. Kanda T, Tsukagoshi H, Oda M, et al. Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson's disease and multiple system atrophy. Acta Neuropathol 1996; 91: 145-154.
22. Snider SR, Fahn S, Isgreen WP, Cote LJ., Primary sensory symptoms in parkinsonism. Neurology 1976; 26: 423-429.
23. Koller WC., Sensory symptoms in Parkinson's disease. Neurology 1984; 34: 957-959.
24. Gierthmühlen J, Schumacher S, Deuschl G, et al. Somatosensory function in asymptomatic Parkin-mutation carriers. Eur J Neurol 2010; 17: 513-517.
25. Gilbert GJ., Biceps pain as the presenting symptom of Parkinson disease: effective treatment with l-dopa. South Med J 2004; 97: 776-777.
26. Weiss HD, Walker MD, Wiernik PH., Neurotoxicity of commonly used antineoplastic agents (second of two parts). N Engl J Med 1974; 291: 127-133.
27. Xiao WH, Bennett GJ., Chemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl- L -carnitine. Pain 2008; 135: 262-270.
28. Tanner KD, Levine JD, Topp KS., Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol 1998; 395: 481-492.
29. Topp KS, Tanner KD, Levine JD., Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol 2000; 424: 563-576.
30. Siau C, Xiao W, Bennett GJ., Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp Neurol 2006; 201: 507-514.
31. Naumann R, Mohm J, Reuner U, et al. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity. Br J Haematol 2001; 115: 323-325.
32. Thomas B, Beal MF., Mitochondrial therapies for Parkinson's disease. Mov Disord 2010; 25 (Suppl 1): S155-S160.
33. Schapira AH., Mitochondrial dysfunction in neurodegenerative diseases. Neurochem Res 2008; 33: 2502-2509.
34. Dalakas MC, Semino-Mora C, Leon-Monzon M., Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2′3′-dideoxycytidine (ddC). Lab Invest 2001; 81: 1537-1544.
35. Mychaskiw G, Pan J, Shah S, et al. Effects of hyperbaric oxygen on skin blood flow and tissue morphology following sciatic nerve constriction. Pain Physician 2005; 8: 157-161.
36. Flatters SJ, Bennett GJ., Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 2006; 122: 245-257.
37. Jin HW, Flatters SJ, Xiao WH, et al. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-l-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol 2008; 210: 229-237.
38. Joseph EK, Levine JD., Mitochondrial electron transport in models of neuropathic and inflammatory pain. Pain 2006; 121: 105-114.
39. Joseph EK, Levine JD., Multiple PKCepsilon-dependent mechanisms mediating mechanical hyperalgesia. Pain 2010; 150: 17-21.
40. Araki E, Nishikawa T., Oxidative stress: a cause and therapeutic target of diabetic complications. J Diabetes Invest 2010; 1: 90-96.
41. Bordet T, Pruss RM., Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain. Neurotherapeutics 2009; 6: 648-662.
42. Joseph EK, Chen X, Bogen O, Levine JD., Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 2008; 9: 463-472.
43. Wang H, Sun H, Della Penna K, et al. Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases. Neuroscience 2002; 114: 529-546.
44. Joseph EK, Levine JD., Caspase signalling in neuropathic and inflammatory pain in the rat. Eur J Neurosci 2004; 20: 2896-2902.
45. Stavrovskaya IG, Kristal BS., The powerhouse takes control of the cell: is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death? Free Radic Biol Med 2005; 38: 687-697.
46. Ouseph AK, Khasar SG, Levine JD., Multiple second messenger systems act sequentially to mediate rolipram-induced prolongation of prostaglandin E2-induced mechanical hyperalgesia in the rat. Neuroscience 1995; 64: 769-776.
47. Spillantini MG, Goedert M., Tau protein pathology in neurodegenerative diseases. Trends Neurosci 1998; 21: 428-433.
48. Aley KO, Reichling DB, Levine JD., Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience 1996; 73: 259-265.
49. Dina OA, Chen X, Reichling D, Levine JD., Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat. Neuroscience 2001; 108: 507-515.
50. Ching GY, Liem RKH., Neuronal intermediate filaments and neurodegenerative diseases. In:, Paramio J, ed. Intermediate filaments. New York: Springer US, 2006: 35-51.
51. Ikemura M, Saito Y, Sengoku R, et al. Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 2008; 67: 945-953.
52. Shishido T, Ikemura M, Obi T, et al. alpha-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure. Neurology 2010; 74: 608-610.
53. Fernyhough P, Gallagher A, Averill SA, et al. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 1999; 48: 881-889.
54. Dina OA, McCarter GC, de Coupade C, Levine JD., Role of the sensory neuron cytoskeleton in second messenger signaling for inflammatory pain. Neuron 2003; 39: 613-624.
55. Gallo G., Tau is actin up in Alzheimer's disease. Nat Cell Biol 2007; 9: 133-134.
56. Fulga TA, Elson-Schwab I, Khurana V, et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 2007; 9: 139-148.
57. Arendt T., Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity. Prog Neurobiol 2003; 71: 83-248.
58. Frasca G, Carbonaro V, Merlo S, et al. Integrins mediate beta-amyloid-induced cell-cycle activation and neuronal death. J Neurosci Res 2008; 86: 350-355.
59. Dina OA, Parada CA, Yeh J, et al. Integrin signaling in inflammatory and neuropathic pain in the rat. Eur J Neurosci 2004; 19: 634-642.
60. Malik-Hall M, Dina OA, Levine JD., Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia. Eur J Neurosci 2005; 21: 3387-3394.
61. Alessandri-Haber N, Dina OA, Joseph EK, et al. Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesia. J Neurosci 2008; 28: 1046-1057.
62. Alessandri-Haber N, Dina OA, Yeh JJ, et al. Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat. J Neurosci 2004; 24: 4444-4452.
63. Ciechanover A, Brundin P., The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 2003; 40: 427-446.
64. Abbruzzese G, Pigullo S, Schenone A, et al. Does parkin play a role in the peripheral nervous system? A family report. Mov Disord 2004; 19: 978-981.
65. Hase A, Yamada H, Arai K, et al. Characterization of parkin in bovine peripheral nerve. Brain Res 2002; 930: 143-149.
66. Okuma Y, Hattori N, Mizuno Y., Sensory neuropathy in autosomal recessive juvenile parkinsonism (PARK2). Parkinsonism Relat Disord 2003; 9: 313-314.
67. Li JY, Henning Jensen P, Dahlstrom A., Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS. Neuroscience 2002; 113: 463-478.
68. Giasson BI, Duda JE, Forman MS, et al. Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons. Exp Neurol 2001; 172: 354-362.
69. Buchman VL, Adu J, Pinon LG, et al. Persyn, a member of the synuclein family, influences neurofilament network integrity. Nat Neurosci 1998; 1: 101-103.
70. Saha AR, Ninkina NN, Hanger DP, et al. Induction of neuronal death by alpha-synuclein. Eur J Neurosci 2000; 12: 3073-3077.
71. Cole LJ, Farrell MJ, Duff EP, et al. Pain sensitivity and fMRI pain-related brain activity in Alzheimer's disease. Brain 2006; 129: 2957-2965.
72. Moalem G, Tracey DJ., Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006; 51: 240-264.
73. Zipp F, Aktas O., The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci 2006; 29: 518-527.